VLP Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:VLP Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10993
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VLP Therapeutics LLC (VLP) is a biopharmaceutical company that develops therapeutic vaccines and next generation of targeted antibody agents to address global unmet medical needs. The company offers product such as vaccines for the treatment of cancer types such as breast, lung, prostate cancer and melanoma, infectious diseases such as HIV-1, dengue and malaria, chronic diseases such as diabetes, asthma and hyperlipidemia; neurological diseases such as alzheimer schizophrenia, and others. Its proprietary i-aVLP vaccine technology is an inserted alphavirus virus-like particle that utilizes chikungunya virus. VLP uses its technology to introduce foreign antigens into specific sites of the envelope protein. The company partners with universities, economic department, industries, cancer centers, and others. VLP is headquartered in Gaithersburg, Maryland, the US.

VLP Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VLP Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 10
VLP Therapeutics Enters into Research Agreement with John’s Hopkins University Bloomberg School of Public Health 11
VLP Therapeutics Enters into Research Agreement with Nagasaki University 12
VLP Therapeutics Enters into Partnership with Mitsubishi Heavy Industries 13
VLP Therapeutics LLC – Key Competitors 14
VLP Therapeutics LLC – Key Employees 15
VLP Therapeutics LLC – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jul 21, 2017: VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer 17
Feb 27, 2017: VLP Therapeutics Appoints Danai Brooks, Managing Partner of Glen Echo Capital, to Advisory Board 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VLP Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VLP Therapeutics LLC, Deals By Therapy Area, 2012 to YTD 2018 8
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 10
VLP Therapeutics Enters into Research Agreement with John’s Hopkins University Bloomberg School of Public Health 11
VLP Therapeutics Enters into Research Agreement with Nagasaki University 12
VLP Therapeutics Enters into Partnership with Mitsubishi Heavy Industries 13
VLP Therapeutics LLC, Key Competitors 14
VLP Therapeutics LLC, Key Employees 15

List of Figures
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VLP Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[VLP Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務情報
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Tinplate Company of India Limited:企業の戦略・SWOT・財務情報
    The Tinplate Company of India Limited - Strategy, SWOT and Corporate Finance Report Summary The Tinplate Company of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • GL Pharm Tech Corp (204840):製薬・医療:M&Aディール及び事業提携情報
    Summary GL Pharm Tech Corp (GL Pharm) is a pharmaceutical company. The company offers drug formulations and delivery technologies for generic marketed drug. It provides incrementally modified drugs, generic drugs, and G-SOREN Tab. GL Pharm provides generic drugs such as olmesartan, atorvastatin, ler …
  • Cabela’s Incorporated:戦略・SWOT・企業財務分析
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Novelis Inc:企業の戦略・SWOT・財務分析
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Groupe PSA:企業の戦略・SWOT・財務分析
    Groupe PSA - Strategy, SWOT and Corporate Finance Report Summary Groupe PSA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Evergreen Packaging Llc
    Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report Summary Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Danaher Corp (DHR):企業の財務・戦略的SWOT分析
    Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Latam Airlines Group S.A.:企業の戦略・SWOT・財務分析
    Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report Summary Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Yanbu National Petrochemicals Co (2290):企業の財務・戦略的SWOT分析
    Summary Yanbu National Petrochemicals Co (YANSAB), a subsidiary of Saudi Basic Industries Corp is a manufacturer and distributor of petrochemical products. The company offers products such as ethylene, linear density polyethylene, polypropylene, butene 1, ethylene glycol, polyethylene, butene 2, MTB …
  • Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hyd …
  • Hornbeck Offshore Services Inc (HOS):石油・ガス:M&Aディール及び事業提携情報
    Summary Hornbeck Offshore Services Inc (HOS) is a provider of marine services. The company offers marine transportation, subsea installation and accommodation support services to exploration and production, oilfield service, offshore construction and the US military customers. It supplies vessels, t …
  • Bladt Industries AS:電力:M&Aディール及び事業提携情報
    Summary Bladt Industries AS (Bladt Industries) is an alternative energy company that offers large scale and complex steel structures. The company offers manufacturing and distribution of steel structures. It offers products for offshore foundations, suctions anchors, offshore substations, modules, t …
  • Combined Motor Holdings Ltd.:企業の戦略・SWOT・財務情報
    Combined Motor Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Combined Motor Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Re-Vana Therapeutics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Cerebrotech Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cerebrotech Medical Systems Inc (Cerebrotech) is a medical device company focused on the development of neurotechnology solutions for non-invasive monitoring of patients after stroke or traumatic brain injury. The company’s Cerebrotech Visor is a portable non-invasive wireless neuro monitori …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆